Fedegari

What does it take to make sterile manufacturing more controlled, reliable and ready for what comes next? At CPHI Milan, this question sat behind many of the conversations we had. We explored challenges across the sterile process, from aseptic transfer and contamination control to process data and alternatives to EtO. Different topics, but a common thread: sterile manufacturing cannot be improved by looking at individual steps in isolation. It requires a deeper understanding of how process design, sterilization, engineering, data and automation work together. That is where Fedegari brings its perspective: combining decades of sterilization expertise with engineering and process understanding to turn complex manufacturing challenges into more controlled and reliable solutions. CPHI gave us the opportunity to bring this perspective into the conversation and, more importantly, to listen to the questions the industry is asking next. Because the future of sterile manufacturing will be shaped not by one technology, but by how we connect the whole process. And now, what comes next? #WeAreFedegari #CPHIMilan #SterileManufacturing #SterilizationByDesign #Pharma

Behind every sterile process, there are challenges to understand, control and continuously improve. Meet Riccardo Cirillo, Area Sales Manager at Fedegari, who will be at A3P Biarritz 2026 to discuss how process expertise and technology can support more robust sterile manufacturing solutions. 📍 Meet Riccardo and the Fedegari team at Booth #09 📅 13–15 October 2026 📌 Biarritz, France

Washing. Packaging. Sterilization. Transfer. Aseptic transfer is an interconnected process, and every transition matters. See where sterility becomes most vulnerable and the innovative approaches to make it more robust.

The challenge isn't simply finding another sterilant. It's understanding how sterilization behaves across materials, geometries and packaging and turning that knowledge into a validated industrial process. Explore what comes next.

Aggregated data tells you how much. Phase-level data shows when and where. Turn phase-level consumption data into actionable insights to optimize resource use, improve process performance and make every improvement measurable.

How do you maintain sterile continuity from stopper treatment to the final transfer into the isolator? At the final sterile interface, any loss of sterility cannot be recovered downstream. Explore why stopper treatment and transfer architecture have become strategic decisions for sterility assurance.